Testing effectiveness (Phase 2)Ended earlyNCT04342897What this trial is testingLY3127804 in Participants With COVID-19Who this might be right forCOVID-19Pneumonia Eli Lilly and Company 95
Not applicableUnknownNCT04367350What this trial is testingProspective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular InvolvementWho this might be right forCOVIDSars-CoV2Corona Virus Infection+2 more University Hospital Tuebingen 500
Large-scale testing (Phase 3)Study completedNCT05007678What this trial is testingTargeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus DiseaseWho this might be right forCOVID-19 Ashford and St. Peter's Hospitals NHS Trust 178
Testing effectiveness (Phase 2)Study completedNCT04551898What this trial is testingSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)Who this might be right forCovid19 BeiGene 181
Not applicableUnknownNCT04270383What this trial is testingClinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in ChildrenWho this might be right for2019-nCoV Beijing Children's Hospital 500
Not applicableUnknownNCT04273646What this trial is testingStudy of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19Who this might be right for2019 Novel Coronavirus PneumoniaCOVID-19 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 48
Not applicableStudy completedNCT07435805What this trial is testingLong-Term Health Effects of Previous Coronavirus Disease 2019 (COVID-19) in Patients Undergoing Preoperative Anesthesia EvaluationWho this might be right forPost-COVID ConditionLong COVIDSequelae of COVID-19 Elazıg Fethi Sekin Sehir Hastanesi 400
Post-approval studies (Phase 4)Ended earlyNCT04346667What this trial is testingPost-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE CompoundsWho this might be right forSARS-CoV-2Coronavirus InfectionAsymptomatic Condition+1 more Government of Punjab, Specialized Healthcare and Medical Education Department 125
Early research (Phase 1)Study completedNCT04932824What this trial is testingLong-term Follow-up to the Phase 1 Study of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine for COVID-19.Who this might be right forCOVID-19 Clover Biopharmaceuticals AUS Pty 137
Large-scale testing (Phase 3)Enrolling By InvitationNCT05787418What this trial is testingHH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2Who this might be right forCOVID-19 Huahui Health 1,200
Not applicableStudy completedNCT04935515What this trial is testingC Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.Who this might be right forCOVID -19 Manimarane Arjunan, MD,DM (Cardiology) 25
Not applicableUnknownNCT04904523What this trial is testingBlood Markers for Identifying & Investigating Infection With COVID19 & Sepsis in Children.Who this might be right forCovid19Sepsis Cardiff University 300
Not applicableUnknownNCT04255940What this trial is testing2019-nCoV Outbreak and Cardiovascular DiseasesWho this might be right forCardiovascular Death; Major Adverse Cardiovascular Events Qilu Hospital of Shandong University 12,000
Not applicableUnknownNCT04768413What this trial is testingEvaluation of a Non-face to Face Multidisciplinary Health Care Model in a Population With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Fundación Universitaria de Ciencias de la Salud 200
Testing effectiveness (Phase 2)Ended earlyNCT04969991What this trial is testingStudy of Varespladib in Patients Hospitalized With Severe COVID-19Who this might be right forCoronavirus Disease 2019Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Ophirex, Inc. 18
Not applicableStudy completedNCT04673279What this trial is testingLong-term COVID-19 Immune Response in a Vulnerable Neighbourhood in ArgentinaWho this might be right forCoronavirus Disease 2019 Hospital Italiano de Buenos Aires 189
Not applicableUnknownNCT04423640What this trial is testingAnalysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19Who this might be right forSARS-CoV-2 Coordinación de Investigación en Salud, Mexico 200
Testing effectiveness (Phase 2)Looking for participantsNCT06684379What this trial is testingStudy on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)Who this might be right forSARS-CoV-2Influenza, HumanRespiratory Syncytial Virus Infections+2 more PEACHES BIOTECH 50
Testing effectiveness (Phase 2)Study completedNCT05567952What this trial is testingLearn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/RitonavirWho this might be right forCOVID-19 Pfizer 436
Not applicableStudy completedNCT04401436What this trial is testingCOVID-19 Associated Lymphopenia Pathogenesis Study in BloodWho this might be right forCoronavirus Disease 2019 National Institute of Allergy and Infectious Diseases (NIAID) 240